Atopic Dermatitis Clinical Trials in Chicago, Illinois

3 studies are recruiting for atopic dermatitis in Chicago, Illinois right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)

    This is a Phase 1b, randomized, placebo/vehicle-controlled, double-blinded, multi-center trial. It is designed to assess the safety and efficacy of S. hominis A9 (ShA9) topical application as a treatment for atopic dermatitis (AD). The trial will enroll adults and pediatric participants with atopic…

    Stage
    Phase 1
    Ages
    6 and older
    Site
    Northwestern University Feinberg School of Medicine: Department of Dermatology, Chicago, Illinois
    Locations
    8 in total
    Run by
    National Institute of Allergy and Infectious Diseases (NIAID)

    See if you can join NCT06504160 on ClinicalTrials.gov

  2. Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With Moderate/Severe Atopic Dermatitis

    Single center, prospective, Open label study of sleep, pruritus and circadian function pre/post 12-weeks of dupilumab treatment in children 6-17 years old

    Stage
    Phase 4
    Ages
    6 to 17
    Site
    Lurie Children's Hospital/Northwestern University, Chicago, Illinois
    Run by
    Northwestern University

    See if you can join NCT05042258 on ClinicalTrials.gov

  3. Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults

    The main aim of the study is to assess real-world effectiveness of nemolizumab in Atopic Dermatitis (AD) as measured by physician assessment and patient reported outcome (PRO) in clinical practice at Month 6.

    Stage
    Not phased
    Ages
    12 and older
    Site
    Galderma Investigational Site 7058, Chicago, Illinois
    Locations
    108 in total
    Run by
    Galderma R&D

    See if you can join NCT06988605 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.